SARS-CoV-2 3CLpro-IN-25
SARS-CoV-2 3CLpro-IN-25 (compound 56) inhibits the SARS-CoV-2 3CLpro with the IC50 of 70 nM and displays antiviral activity in cells with the EC50 of 3.1 μM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-25.html
Smiles
O=C(N1C2=CC(OCO3)=C3C=C2N=C1SC)C4=CC=C(C)C=C4
Molecular Formula
C17H14N2O3S
Molecular Weight
326.37
References & Citations
[1]Fatima-Zahra Chaibi, et al. N-acylbenzimidazoles as selective Acylators of the catalytic cystein of the coronavirus 3CL protease. Eur J Med Chem. 2024 Oct 5:276:116707.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog